Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 48

Results For "IFF"

1267 News Found

Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in NAFLD patients with comorbidities
Diagnostic Center | June 10, 2023

Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in NAFLD patients with comorbidities

The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52


Cosette Pharmaceuticals acquires Intrarosa from Endoceutics
News | June 09, 2023

Cosette Pharmaceuticals acquires Intrarosa from Endoceutics

Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product


Zydus receives final approval from USFDA for Esomeprazole Magnesium
Drug Approval | June 09, 2023

Zydus receives final approval from USFDA for Esomeprazole Magnesium

Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023)


Bayer partners with biotech firm on lipid nanoparticle delivery systems
Biotech | June 08, 2023

Bayer partners with biotech firm on lipid nanoparticle delivery systems

Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.


JB Pharma completes 1 year of its identity launch
News | June 07, 2023

JB Pharma completes 1 year of its identity launch

Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23


Dr. Reddy's completes Phase I study (IV route) of a proposed biosimilar of tocilizumabp
News | June 06, 2023

Dr. Reddy's completes Phase I study (IV route) of a proposed biosimilar of tocilizumabp

The successful outcome of this study represents an important milestone in Dr. Reddy's commitment to make highquality biosimilar products more accessible and affordable


Keytruda+ chemotherapy improves overall survival versus chemotherapy alone for unresectable advanced pleural mesothelioma
Diagnostic Center | June 05, 2023

Keytruda+ chemotherapy improves overall survival versus chemotherapy alone for unresectable advanced pleural mesothelioma

In Phase 3 CCTG IND.227/KEYNOTE-483 trial, KEYTRUDA plus chemotherapy also demonstrated statistically significant improvements in PFS and ORR compared to chemotherapy alone


Evonik launches next-generation peptide for biopharma applications
News | June 02, 2023

Evonik launches next-generation peptide for biopharma applications

One thousand times more soluble than L-cystine at neutral pH


Lonza acquires biotech firm Synaffix
News | June 02, 2023

Lonza acquires biotech firm Synaffix

Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology


SÜDPACK Medica and Liveo Research join forces at Connect in Pharma in Geneva
News | May 29, 2023

SÜDPACK Medica and Liveo Research join forces at Connect in Pharma in Geneva

The PP-based top and bottom webs are manufactured in a unique coextrusion process